Calithera Biosciences (CALA) Misses Q4 EPS by 9c

Calithera Biosciences (NASDAQ: CALA) reported Q4 EPS of ($0.31), $0.09 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $7.25 million versus the consensus estimate of $5.46 million.

For earnings history and earnings-related data on Calithera Biosciences (CALA) click here.

You May Also Be Interested In

• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Etsy upgraded to buy at BofA on durable growth, buyback potential